Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric suit may ease stroke stiffness and improve balance

NCT ID NCT06702163

Symptom relief Sponsor: Institut De La Colonne Vertebrale Et Des Neurosciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested the EXOPULSE Mollii suit, a full-body garment with 58 electrodes, in 30 stroke survivors who had muscle stiffness (spasticity) and balance problems. The suit stimulates muscles to reduce spasticity and improve balance. Researchers measured balance changes using the Berg Balance Scale after active and sham sessions, and after 4 weeks of regular use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EXOPULSE Mollii suit (a full-body garment with 58 electrodes that stimulate muscles to reduce spasticity)
What this could lead to
If it works, this could offer a non-drug option to help stroke survivors with spasticity improve their balance and mobility.
What could go wrong
This was a small, completed trial with only 30 participants, so results may not apply to everyone. The device is not a cure and only targets symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Dec 2022

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 75 years. * Having a clinical diagnosis of stroke for at least three months. * Being able to walk freely or with the need of support (modified Rankin score * 4). * Being a French speaker, able to understand verbal instructions, and affiliated. with the national health insurance (sécurité social). * Having spasticity with a score of at least 1+ on the MAS. * Having a Berg Balance Scale score ≤46 associated across the literature with a risk of fall. Exclusion Criteria: * Being included in another research protocol during the study period. * Inability to undergo medical monitor for the study purposes due to geographical or social reasons. * Having contraindications for using EXOPULSE Mollii suit (having implanted electronic medical devices or equipment which can be disrupted by magnets or an electronic life support equipment or high-frequency operation equipment; e.g., cardiac stimulator, ventriculoperitoneal shunt, intrathecal baclofen pump). * Being pregnant (confirmed by a blood beta-HCG test). * Having a change in their pharmacological therapy in the last three months. * Suffering from other somatic or neuropsychiatric diagnoses (e.g., arrhythmias, uncontrolled epilepsy, diseases causing osteoarticular and muscular pain). * Having a body mass index above 35 Kg/m2. * In case of introducing a medical device other than EXOPULSE Mollii suit during the study period. * Patients under juridical protection (" mesure de protection) judiciare : tutelle, curatelle, sauvegarde de justice ") * Patients deprived of freedom (" personnes privées de liberté ".)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spasticity as sequela of stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Muscle Spasticity stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spasticity as sequela of stroke

Contacts and locations

Locations

  • Clinical Neurophysiology department, Henri Mondor Hospital, Creteil, France

    Créteil, VAL DE MARNE, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.